Clinical evaluation of the effect of attenuation correction technique on18F-fluoride PET images

Annals of Nuclear Medicine

Volumn 21, Issue 2, 2007, Pages 93-99

  Tayama, Yoshibumi ^a   Takahashi, Nobukazu ^a   Oka, Takashi ^a   Takahashi, Akira ^a   Aratake, Masato ^a   Saitou, Tomoyuki ^a   Inoue, Tomio ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Attenuation correction; Bone to muscle ratio; PET

Indexed keywords

FLUORINE 18; OXYGEN 18;

ADULT; AGED; ARTICLE; BONE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; FEMUR HEAD; HUMAN; LUMBAR VERTEBRA; MALE; MUSCLE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; WHOLE BODY IMAGING;

EID: 33947710007     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033986     Document Type: Article

References (20)

1. Blau M, Nagler W, Bender MA. Fluorine-18: a new isotope for bone scanning. J Nucl Med 1962; 3: 332-334.
2. Tocharoenchai C, Tsui BM, Frey EC, Wang WT. Effect of attenuation correction on lesion detection using a hybrid PET system. J Med Assoc Thai 2005; 88: 96-102.
3. Green JR, Reeve J, Tellez M, Veall N, Wootton R. Skeletal blood flow in metabolic disorders of the skeleton. Bone 1987; 8: 293-297.
4. Nahmias C, Cockshott WP, Belbeck LW, Garnett ES. Measurement of absolute bone blood flow by positron emission tomography. Skeletal Radiol 1986; 15: 198-200.
5. 18F in rabbit bone. Clin Phys Physiol Meas 1986; 7: 333-343.
6. Wootton R, Reeve J, Veall N. The clinical measurement of skeletal blood flow. Clin Sci Mol Med 1976; 50: 261-268.
7. Hawkins RA, Choi Y, Huang SC, Hoh CK, Dahlbom M, Schiepers C, et al. Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. J Nucl Med 1992; 33: 633-642.
8. 18F-fluoride positron emission tomography in postmenopausal women. J Bone Miner Res 2000; 15: 763-769.
9. 18F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med 2001; 42: 1800-1804.
10. Schirrmeister H, Guhlmann A, Kotzerke J, Santjohanser C, Kuhn T, Kreienberg R, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol 1999; 17: 2381-2389.
11. 18F-Fluoride PET/CT. J Nucl Med 2006; 47: 287-297.
12. Schoder H, Larson SM. Related Articles. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004; 34: 274-292.
13. Seto E, Segall GM, Terris MK. Related Articles. Positron emission tomography detection of osseous metastases of renal cell carcinoma not identified on bone scan. Urology 2000; 55: 286.
14. Hetzel M, Arslandemir C, Konig HH, Buck AK, Nussle K, Glatting G, et al. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res 2003; 18: 2206-2214.
15. Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004; 34 (4): 274-292.
16. Wootton R, Reeve J, Spellacy E, Tellez-Yudilevich M. Skeletal blood flow in Paget's disease of bone and its response to calcitonin therapy. Clin Sci Mol Med 1978; 54: 69-74.
17. Reeve J, Arlot M, Wootton R, Edouard C, Tellez M, Hesp R, et al. Skeletal blood flow, iliac histomorphometry, and strontium kinetics in osteoporosis: a relationship between blood flow and corrected apposition rate. J Clin Endocrinol Metab 1988; 66: 1124-1131.
18. 18F-fluoride positron emission tomography. J Bone Miner Res 2003; 18: 2215-2222.
19. Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med 2003; 44: 930-942.
20. 18F PET. J Nucl Med 1999; 40 (10): 1623-1629.